https://investor.ironwoodpharma.com/press-releases/press-release-details/2022/Ironwood-Pharmaceuticals-Reports-Second-Quarter-2022-Results-Maintains-Full-Year-Guidance-Due-to-Continued-Strength-of-LINZESS-Prescription-Demand/default.aspx
https://investor.ironwoodpharma.com/press-releases/press-release-details/2022/Ironwood-Pharmaceuticals-Reports-Second-Quarter-2022-Results-Maintains-Full-Year-Guidance-Due-to-Continued-Strength-of-LINZESS-Prescription-Demand/default.aspx